GeneKor’ s Scientific Team has over 15 years of experience in cancer genetics and has performed thousands of hereditary cancer tests. The HerediGENE test is designed in order to have a very high sensitivity and specificity. All the findings from the analysis of each patient’s sample are classified by using the most reliable and updated databases.LEARN MORE
Hereditary Cancer Risk Assessment: Is it Important?
Knowledge of the risk for hereditary cancer provides physicians with several different options for the management of a patient:
- International management guidelines are available for a number of syndromes associated with hereditary cancer predisposition.
- Dramatic reduction in the occurrence of primary tumors can be achieved.
- International guidelines recognize the value of the use of hereditary gene panels.
- Novel targeted therapy drugs have been and are being developed. They are designed to target the specific mutated protein, individualizing the treatment of the patients.